FBTAX Mutual Fund

NAV$45.56
Showing 10 of 92 holdings(as of Jan 31, 2026)Top 10 Weight: 53.22%
#TickerNameWeightSharesMkt ValueShare ChgSectorIndustry
1ABBVAbbvie Inc16.61%1,389,580$309.89M••••••••••••••••••••••
2GILDGilead Sciences Inc6.57%864,100$122.66M••••••••••••••••••••••
3ALNYAlnylam Pharmace5.02%277,186$93.71M••••••••••••••••••••••
4ASND:COAscendis Pharma As Adr4.49%370,625$83.80M••••••••••••••••••••••
5COGTCogent Biosciences Inc3.83%1,988,418$71.40M••••••••••••••••••••••
6ARGX:ASArgenx Se Spon Adr Each Rep 1 Ord Shs3.65%81,000$68.08M••••••••••••••••••••••
7NMFFidelity Securities Lending Cash Central Fund3.59%66,938,144$66.94M••••••••••••••••••••••
8INSMInsmed Inc3.47%412,300$64.68M••••••••••••••••••••••
9VRDNViridian Therapeutics Inc3.15%1,782,464$58.82M••••••••••••••••••••••
10BIIBBiogen Inc. Com2.84%294,100$52.91M••••••••••••••••••••••
Want to see all 92 holdings?View All HoldingsPRO

Top Holdings Themes

PharmaceuticalsBiotechnologyMedical DevicesImmunologyOncologyDigital HealthLife Sciences ToolsBiotechnology Tools

FBTAX Mutual Fund Top Holdings

FBTAX holdings top 10 positions. The top 10 holdings account for 53.2% of the fund, led by Abbvie Inc at 16.6%, Gilead Sciences Inc at 6.6%, Alnylam Pharmace at 5.0%.

FBTAX portfolio concentration is relatively high, with the top 10 representing 53.2% of total assets. The largest sector exposure is Health Care at 93.4%.

FBTAX sector allocation provides a detailed breakdown. FBTAX overlap tool shows how holdings compare to other funds in your portfolio.